Abstract
PURPOSE: Safety and efficacy of a novel automated ray tracing optimization in customization of excimer ablation in myopic LASIK. METHODS: In a consecutive case series, 25 patients (50 eyes) undergoing femtosecond-laser-assisted myopic LASIK were evaluated. The novel, artificial-intelligence platform initially calculates the ablation profile based on a model eye for each case, based on interferometry axial length data. Low- and high-order aberration calculation is performed by raytracing based on wavefront and Scheimpflug tomography measurements, all from a single diagnostic device. Visual acuity, refractive error, keratometry, topography, high-order aberrations and contrast sensitivity were evaluated, over six months follow-up. RESULTS: Change from pre- to 6 months post-operative: mean refractive error improved from -5.06 ± 2.54 diopters (D) (range -8.0 to -0.50 D) to -0.11 ± 0.09 D (range -0.25 to + 0.25); refractive astigmatism from -1.07 ± 0.91 D (range -4.25 to 0 D) to -0.15 ± 0.04 D (range -0.25 to 0); and topographic astigmatism from -1.65 ± 0.85 D to -0.26 ± 0.11 D (range -0.60 to 0). About 65% of eyes gained one line of vision and 38% 2 lines. Pre- to post-operative high-order aberration average: RMSh changed from 0.25 um to 0.35 um. Contrast sensitivity improved post-operatively. CONCLUSION: We report safe and effective preliminary outcomes with a novel excimer laser customization by ray tracing optimization, for myopic LASIK treatments, employing several independent up-till-now diagnostics and a customized eye model reference for each case. It bears the potential advantage through total eye aberration data and ray tracing refraction calculation to offer improved and more predictable visual outcomes.